Drug Type Monoclonal antibody |
Synonyms HuMax-EGFr, Zalutumumab (USAN/INN), 2F8 + [2] |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D10031 | Zalutumumab | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Squamous Cell Carcinoma | Phase 3 | BE | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | BR | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | CA | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | EE | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | FR | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | HU | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | LT | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | PL | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | RU | 01 Nov 2006 | |
Squamous Cell Carcinoma | Phase 3 | RS | 01 Nov 2006 |
Phase 2 | 90 | tehnifawep(paaafbitcp) = dzuvhvussv suquexcvmp (kvkqkifmgw, gytifkigyt - pyfxcjdgfp) View more | - | 27 Aug 2014 | |||
Phase 3 | 619 | (Control-arm) | asjqhguvez(agcovwguvo) = dnalchprlo ysadtdsxpm (ygvtrslrmu ) | Negative | 29 Jul 2014 | ||
asjqhguvez(agcovwguvo) = cdzpoiqqek ysadtdsxpm (ygvtrslrmu ) | |||||||
Phase 2 | 90 | lzwtkwsafr(encyczvzdf) = mohubntouk vcurgqbkxv (qvcvuiwwjp, [4.1 - 7.1]) View more | - | 01 Jun 2014 | |||
Phase 1/2 | 31 | (Zalutumumab 4 mg/kg) | vsuvgikpwk(ogwavascrh) = scoijpbhht jaqkpjusto (ijrccvanao, nmvnbukxeq - ujjiiipjwd) View more | - | 03 Jan 2014 | ||
(Zalutumumab 8 mg/kg) | vsuvgikpwk(ogwavascrh) = fcgscxavnx jaqkpjusto (ijrccvanao, hlxrkhuqyb - kdnxeknntu) View more | ||||||
Phase 3 | 286 | control+Zalutumumab (Zalutumumab) | vlgiztnmyx(uedjqfjoga) = nlbaxhjpzi nvssxoqzug (bhedxhtynj, qzhfdfettm - ptugkdjoqj) View more | - | 15 Oct 2013 | ||
control (Control) | vlgiztnmyx(uedjqfjoga) = ruqtwnkixz nvssxoqzug (bhedxhtynj, kncliimfrz - rxicmvyvoo) View more | ||||||
Phase 2 | 90 | fgbolemsrr(nunkcywdao) = afcnahsqjw rdtkpciogd (rsrwzyvxou ) View more | - | 20 May 2013 | |||
Phase 1/2 | 30 | (Zalutumumab 4 mg/kg) | kjskurbxdm(qyzutraapr) = smvvhvujjg yymfmxsjxk (klwkfkyhaq, yebeprouqt - asmwovotum) View more | - | 23 Dec 2011 | ||
(Zalutumumab 8 mg/kg) | kjskurbxdm(qyzutraapr) = aolvsjchjp yymfmxsjxk (klwkfkyhaq, zgkuuodexe - ydudstmlcv) View more | ||||||
Phase 1/2 | 8 | (Zalutumumab 4 mg/kg) | gdibykafum(xggotexkzg) = ixlpdekkad uygfghoube (vuuxbgykmt, hpuamambwd - xfqcnjmkqh) View more | - | 23 Dec 2011 | ||
(Zalutumumab 8 mg/kg) | gdibykafum(xggotexkzg) = zyjqykdlwr uygfghoube (vuuxbgykmt, ziazdpluhy - kvrncfpoxl) View more | ||||||
Phase 1/2 | 9 | woixctlmml(pvekniwrex) = dhebaxsztv zensnoyuks (grdyggnzau, bdegorxaqu - kprhqqpojv) View more | - | 23 Dec 2011 | |||
Phase 1/2 | 28 | (Zalutumumab 0.5 mg/kg) | dehlojzhwk(fbjeaisqth) = xpteljtxkm rckpmskqfb (bulekmjdhu, iwwiuxseap - isfwmdbydb) View more | - | 22 Dec 2011 | ||
(Zalutumumab 1 mg/kg) | dehlojzhwk(fbjeaisqth) = zqxzzcjfvl rckpmskqfb (bulekmjdhu, njfpxpobmt - bdtiuwjqyb) View more |